Skip to main content
. 2015 Jun 2;2015(6):CD011438. doi: 10.1002/14651858.CD011438.pub2

Comparison 4. Sensitivity analysis excluding the cross‐over trial.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Exacerbations (oral corticosteroid) 1   Odds Ratio (IV, Random, 95% CI) Totals not selected
2 Asthma Quality of Life Questionnaire (AQLQ) total 3 1745 Mean Difference (IV, Random, 95% CI) ‐0.11 [‐0.19, ‐0.03]
3 Serious adverse events (SAEs) (all) 3 1839 Odds Ratio (IV, Random, 95% CI) 0.79 [0.30, 2.07]